Standard Biotools (LAB) Gross Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn | 264.00 |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn | 8.00 |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | -316.00 |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 73.00 |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | 90.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -3,577.00 |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 113.00 |
| 10 | Standard Biotools | 252.98 Mn | -223.74 Mn | 10.54 Mn | 324.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 324.00 |
| Mar 31, 2026 | 458.00 |
| Dec 31, 2025 | 651.00 |
| Sep 30, 2025 | 1,256.00 |
| Jun 30, 2025 | 2,526.00 |
| Mar 31, 2025 | -3,809.00 |
| Sep 30, 2024 | -424.00 |
| Jun 30, 2024 | -4,768.00 |
| Mar 31, 2024 | -1,132.00 |
| Dec 31, 2023 | -4,643.00 |
| Sep 30, 2023 | -821.00 |
| Jun 30, 2023 | 379.00 |
| Mar 31, 2023 | 181.00 |
| Dec 31, 2022 | -1,381.00 |
| Sep 30, 2022 | -1,628.00 |
| Jun 30, 2022 | -3,091.00 |
| Mar 31, 2022 | 3,630.00 |
| Sep 30, 2021 | 451.00 |
| Jun 30, 2021 | 4,238.00 |
| Mar 31, 2021 | 1,125.00 |